Clinical study of parathyroid gland and its function protection by intermediate approach in thyroid surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300073868

Enrollment

Unknown

Registered

2023-07-24

Start date

2023-08-01

Completion date

Unknown

Last updated

2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid cancer

Interventions

Test Group:Receiving two ICG injections (one before and one after thyroidectomy, the first injection to identify the parathyroid gland before thyroidectomy and the second injection to assess vasculari

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) Age = 18 years; 2) Patients who underwent unilateral/bilateral thyroidectomy for thyroid cancer; 3) Patient is eligible for surgery; 4) Patient is mentally well and able and willing to comply with study procedures; 5) Patient is able and willing to give written informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with hypersensitivity to ICG or iodinated contrast agents 2) Pregnant or lactating women 3) The patient had a history of previous thyroid surgery, neck surgery, neck trauma, and neck chemoradiotherapy. 4) Patient has parathyroid disease

Design outcomes

Primary

Measure	Time frame
Changes in Parathyroid Hormone (PTH) Levels;	—

Secondary

Measure	Time frame
Blood calcium level;Serum thyroid-stimulating hormone (TSH) level;Thyroglobulin (TG) level;	—

Countries

China

Contacts

Public ContactYuan Jianming

Ruijin Hospital Luwan Branch Shanghai JiaoTong University School of Medicine

13918716642@139.com+86 139 1871 6642

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026